Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $514000.0.

  • Rapid Micro Biosystems' Change in Inventory rose 39204.55% to $514000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $580000.0, marking a year-over-year decrease of 4978.35%. This contributed to the annual value of $335000.0 for FY2024, which is 12808.05% up from last year.
  • According to the latest figures from Q3 2025, Rapid Micro Biosystems' Change in Inventory is $514000.0, which was up 39204.55% from $44000.0 recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Change in Inventory registered a high of $3.6 million during Q2 2022, and its lowest value of -$1.1 million during Q4 2024.
  • For the 5-year period, Rapid Micro Biosystems' Change in Inventory averaged around $704421.1, with its median value being $514000.0 (2025).
  • Within the past 5 years, the most significant YoY rise in Rapid Micro Biosystems' Change in Inventory was 2562500.0% (2024), while the steepest drop was 35193.13% (2024).
  • Over the past 5 years, Rapid Micro Biosystems' Change in Inventory (Quarter) stood at $1.5 million in 2021, then plummeted by 75.58% to $371000.0 in 2022, then tumbled by 162.8% to -$233000.0 in 2023, then plummeted by 351.93% to -$1.1 million in 2024, then skyrocketed by 148.81% to $514000.0 in 2025.
  • Its Change in Inventory was $514000.0 in Q3 2025, compared to $44000.0 in Q2 2025 and $1.1 million in Q1 2025.